Heat shock protein family A (Hsp70) Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $193.00 $357.00 | 13 | |
Binds to the nucleotide-binding domain, preventing ATP binding. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $93.00 $356.00 | 13 | |
Disrupts protein-protein interactions, leading to HSPA inhibition. | ||||||
MKT-077 | 147366-41-4 | sc-507514 | 5 mg | $175.00 | ||
Binds to the mitochondrial HSPA, impairing its chaperone activity. | ||||||
GW 0742 | 317318-84-6 | sc-203991 sc-203991A | 10 mg 50 mg | $190.00 $815.00 | 11 | |
Covalently modifies HSPA, leading to disruption of its function. | ||||||
JG-98 | 1456551-16-8 | sc-507517 | 5 mg | $220.00 | ||
Blocks HSPA interaction with its co-chaperones. | ||||||
Oncrasin 1 | 75629-57-1 | sc-204146 sc-204146A | 10 mg 50 mg | $145.00 $615.00 | 2 | |
Inhibits HSPA function by interfering with nucleotide exchange. | ||||||
4-[4-Fluoro-3-[(4-methoxypiperidin-1-yl)carbonyl]benzyl]phthalazin-1(2H)-one | 1174043-16-3 | sc-497005 | 5 mg | $430.00 | ||
Induces degradation of HSPA through the ubiquitin-proteasome pathway. | ||||||
Brassinolide | 72962-43-7 | sc-391736 sc-391736A | 2 mg 10 mg | $104.00 $332.00 | 2 | |
Modulates HSPA activity by affecting its ATPase cycle. | ||||||